Marksans Pharma Limited (NSE:MARKSANS)
India · Delayed Price · Currency is INR 302.90
-8.10 (-2.60%)
Oct 19, 2026, 3:30 PM IST
Marksans Pharma Market Cap
Marksans Pharma has a market cap or net worth of 137.33 billion as of October 19, 2026. It is the 8,066th most valuable company in the world and the 490th biggest in India. Its market cap has increased by 71.17% in one year.
Market Cap
137.33B
Enterprise Value
131.15B
Revenue
31.72B
Global Rank
Country Rank
#490 India
PE Ratio
26.59
ChartMarket Cap Chart
Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 137.33B, an increase of 3,660.89%. That is a compound annual growth rate of 20.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 137.33B | 68.09% |
| Dec 31, 2025 | 81.70B | -39.22% |
| Dec 31, 2024 | 134.43B | 84.14% |
| Dec 29, 2023 | 73.00B | 210.96% |
| Dec 30, 2022 | 23.48B | -4.66% |
| Dec 31, 2021 | 24.63B | -0.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.18T |
| Divi's Laboratories | 2.41T |
| Laurus Labs | 1.12T |
| Lenskart Solutions | 1.11T |
| Dr. Agarwal's Health Care | 148.37B |
| NATCO Pharma | 143.83B |
| Indegene | 142.60B |
| Vijaya Diagnostic Centre | 140.65B |